FOX BIZ NEWS: Johnson & Johnson under pressure as FDA approves new use for Xarelto

Johnson & Johnson under pressure as FDA approves new use for Xarelto



Johnson & Johnson shares were flat in trading Monday as legal troubles clouded its financial outlook.